Risk Factors for Repeatedly Reactive HIV-1 EIA and Indeterminate Western Blots: A Population-Based Case-Control Study

Connie L. Celum, Robert W. Coombs, Margie Jones, Victory Murphy, Lloyd Fisher, Christopher Grant, Lawrence Corey, Thomas Inui, Mark H. Wener, King K. Holmes

Research output: Contribution to journalArticle

63 Scopus citations

Abstract

Objective: Causes of indeterminate results of Western blot testing (IWB) for human immunodeficiency virus (HIV) type 1 include seroconversion, HIV-2 cross-reactivity, and autoimmune disease, but most IWB results remain unexplained. This case-control study assessed risk factors for IWB results, including early HIV infection, other retroviral infection, autoantibodies, and other medical conditions. Design: Prospective study to determine HIV seroconversion rate, with a case-control design to assess other risk factors for IWB. Cases (persons with one or more repeatedly reactive HIV-1 enzyme immunoassay with IWB), their current sexual partners, and controls (persons with negative enzyme immunoassay and Western blot results) were recruited from blood banks, health department and prenatal clinics, and private providers in Washington and Oregon. Results: Of 244 cases enrolled, 206 were followed up for 6 months or longer, and six (3.0%; 95% confidence interval [CI], 0.7% to 5.3%) with recent HIV risk behaviors seroconverted. The Western blot banding patterns differed among groups; cases usually had p17 or p24 bands, while controls and cases’ sexual partners usually had polymerase bands. Conditional logistic regression indicated that independent risk factors for IWB among male cases and controls were a tetanus booster in the past 2 years (odds ratio, 3.2; 95% CI, 1.2 to 8.6) and sexual contact with a prostitute (odds ratio, 3.0; 95% CI, 1.0 to 9.5). Independent risk factors for women were parity (odds ratio, 1.2;95%CI, 1.02 to 1.4) and autoantibodies, either rheumatoid factor or antinuclear antibodies (odds ratio, 2.3; 95% CI, 1.03 to 5.6). No cross-reactivity was detected with HIV-2, human T-lymphotrophic virus type 1, feline immunodeficiency or feline leukemia, or bovine immunodeficiency viruses. Conclusions: Evaluation of persons with reactive HIV-1 enzyme immunoassays and IWB should include an assessment of HIV risk and other possible risk factors, such as alloimmunization (ie, parity or recent immunization) or autoantibodies (ie, antinuclear antibodies and rheumatoid factor). The relationship of IWB among men who reported sex with prostitutes is intriguing and warrants further study.

Original languageEnglish (US)
Pages (from-to)1129-1137
Number of pages9
JournalArchives of Internal Medicine
Volume154
Issue number10
DOIs
StatePublished - May 23 1994

    Fingerprint

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Celum, C. L., Coombs, R. W., Jones, M., Murphy, V., Fisher, L., Grant, C., Corey, L., Inui, T., Wener, M. H., & Holmes, K. K. (1994). Risk Factors for Repeatedly Reactive HIV-1 EIA and Indeterminate Western Blots: A Population-Based Case-Control Study. Archives of Internal Medicine, 154(10), 1129-1137. https://doi.org/10.1001/archinte.1994.00420100115015